published meta-analysis   sensitivity analysis   studies

potential COVID-19 treatments in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsZhang, 2020 0.50 [0.17; 1.50] 0.50[0.17; 1.50]Zhang, 202010%56NAnot evaluable deathsdetailed resultsCao, 2020 0.15 [0.01; 3.29] Zhang, 2020 0.50 [0.17; 1.50] 0.44[0.16; 1.23]Cao, 2020, Zhang, 202020%97moderatenot evaluable deaths (time to event analysis only)detailed resultsZhang, 2020 0.50 [0.17; 1.50] 0.50[0.17; 1.50]Zhang, 202010%56NAnot evaluable clinical deteriorationdetailed resultsCao, 2020 0.11 [0.01; 2.21] Zhang, 2020 0.87 [0.23; 3.27] 0.49[0.08; 3.03]Cao, 2020, Zhang, 2020235%97moderatenot evaluable clinical improvementdetailed resultsCao, 2020 1.67 [0.84; 3.33] 1.67[0.84; 3.33]Cao, 202010%42NAnot evaluable clinical improvement (14-day)detailed resultsCao, 2020 2.00 [0.58; 6.94] 2.00[0.58; 6.94]Cao, 202010%41NAnot evaluable clinical improvement (21-day)detailed resultsCao, 2020 1.50 [0.22; 10.08] 1.50[0.22; 10.08]Cao, 202010%41NAnot evaluable clinical improvement (7-day)detailed resultsCao, 2020 2.38 [0.38; 14.70] 2.38[0.38; 14.70]Cao, 202010%41NAnot evaluable clinical improvement (time to event analysis only)detailed resultsCao, 2020 1.67 [0.84; 3.33] 1.67[0.84; 3.33]Cao, 202010%42NAnot evaluable radiologic improvement (14-day)detailed resultsCao, 2020 5.54 [1.01; 30.50] 5.54[1.01; 30.50]Cao, 202010%41NAnot evaluable serious adverse eventsdetailed resultsCao, 2020 0.11 [0.01; 2.21] 0.11[0.01; 2.21]Cao, 202010%41NAnot evaluable adverse eventsdetailed resultsCao, 2020 1.60 [0.38; 6.81] 1.60[0.38; 6.81]Cao, 202010%41NAnot evaluable0.010.01.0relative treatment effectwww.metaEvidence.org2024-05-06 19:27 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 290,547,608,830,831,829,901,680,595,828,681,1209,833,629,689,543,617,625,859,511,960,546,564,944,682,1266,943,894,560,1102,598,563,668,753,752,836,639,541,534,581,615,679,522,582,666,1149,1150,737,544,733,597,524,611,538,957,958,521,566,517,881,904,882,897,896,899,1235,898,687,740,883,947,536,591,729,887,742,878,975,570,771,888,1141,690,880,1255,567,596,1437,600,652,557,635,1236,553,628,646,645,607,395,920,1438,927,932,931,1263,599,614,942,1436,928,923,535,1046,727,818,606,954,964,962,963,1045,638,677,627,533,526,616,926,1246,726,580,568,527,588,539,585,691,1210,525,843,827,1047,1048,819,545,1253,519,619,537,514,688,529,508,656,657,832,530,512,515,754,1142,1419,513,884,632,559,889,956,684,886,631,574,509,542,1145,555,554,941,961,1250,633,676,518,532,510,528,520,955,815,893,623,622,630,593,569,516,814,649,650,589,651,968,1245,610,751,747,695,548,970,594,565,879,1257,571,626,697,572,1234,586,573,540,592,930,949,838,698,934,735,929,948,946,945,587,655,1146,531,933,613,919,725,678,921,621,959,748,1348,1256,924,1243,925,658,699,612,552,590,891,605,892,722,618,609,551,834,763,922,935,620,1317,1265,824,766,857,1291,1088,1331,1330,1329,1344,1328,1327,979,822,762,805,950,757,761,806,758,826,755,821,1288,1287,1286,760,1284,802,765,1285,759,823,804,1264,764,858,835,1262,1290,1316,1341,1342,1343,825,803,1244,523,885,734,1439 - roots T: 290